Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Major Depressive Disorder

NCT00157547 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00157547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00157547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Major Depressive Disorder
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2003
Completion date
August 31, 2006
Enrollment
95 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder